TRIM33 and clinically amyopathic dermatomyositis: The sensitivities and specificities of anti-TIF1-gamma autoantibody positivity in relation to CADM diagnosis by in-house ELISA, IP and LB assays are presented in supplementary Figs S1 and S2, available at Rheumatology online.